loadpatents
name:-0.043453931808472
name:-0.0311279296875
name:-0.012421846389771
VANDYCK; Koen Patent Filings

VANDYCK; Koen

Patent Applications and Registrations

Patent applications and USPTO patent grants for VANDYCK; Koen.The latest application filed is for "fused heterocycle derivatives".

Company Profile
20.45.57
  • VANDYCK; Koen - Paal-Beringen BE
  • Vandyck; Koen - Beringen BE
  • Vandyck; Koen - Paal BE
  • Vandyck; Koen - Paal-Beringer BE
  • VANDYCK; Koen - Beringen-Paal BE
  • Vandyck; Koen - Mechelen N/A BE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Fused Heterocycle Derivatives
App 20220242879 - KUDUK; Scott D. ;   et al.
2022-08-04
Oxindoles And Methods Of Use Thereof
App 20220143031 - McGowan; David Craig ;   et al.
2022-05-12
2-pyridones And Methods Of Use Thereof
App 20220143032 - McGowan; David Craig ;   et al.
2022-05-12
Bicyclic Pyridazinones And Methods Of Use Thereof
App 20220144811 - McGowan; David Craig ;   et al.
2022-05-12
Compounds Targeting Prmt5
App 20220112194 - Vandyck; Koen ;   et al.
2022-04-14
Compounds Targeting Prmt5
App 20220048922 - Vandyck; Koen ;   et al.
2022-02-17
Anti-viral Compounds
App 20220009903 - Vandyck; Koen ;   et al.
2022-01-13
Modulators Of Thr-beta And Methods Of Use Thereof
App 20220009924 - McGowan; David Craig ;   et al.
2022-01-13
Compounds targeting PRMT5
Grant 11,198,699 - Vandyck , et al. December 14, 2
2021-12-14
Modulators Of Thr-beta And Methods Of Use Thereof
App 20210355112 - Vandyck; Koen ;   et al.
2021-11-18
Capsid Assembly Modulator Dosing Regimen
App 20210260025 - VANDYCK; Koen ;   et al.
2021-08-26
Modulators of THR-.beta. and methods of use thereof
Grant 11,091,467 - Vandyck , et al. August 17, 2
2021-08-17
Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
Grant 11,078,193 - Vandyck , et al. August 3, 2
2021-08-03
Cyclized Sulfamoylarylamide Derivatives And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20210179635 - VENDEVILLE; Sandrine Marie Helene ;   et al.
2021-06-17
Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B
Grant 10,995,064 - Vandyck , et al. May 4, 2
2021-05-04
Capsid assembly modulator dosing regimen
Grant 10,973,801 - Vandyck , et al. April 13, 2
2021-04-13
Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B
Grant 10,941,113 - Vandyck , et al. March 9, 2
2021-03-09
Sulfamoyl-arylamides And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20210024462 - VANDYCK; Koen ;   et al.
2021-01-28
Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
Grant 10,875,876 - Vendeville , et al. December 29, 2
2020-12-29
Modulators Of Thr-beta And Methods Of Use Thereof
App 20200354345 - Vandyck; Koen ;   et al.
2020-11-12
Compounds Targeting Prmt5
App 20200317686 - Vandyck; Koen ;   et al.
2020-10-08
Sulfamoyl-arylamides And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20200255373 - Kind Code
2020-08-13
Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B
Grant 10,676,429 - Vandyck , et al.
2020-06-09
Sulphamoylaryl derivatives and use thereof as medicaments for the treatment of liver fibrosis
Grant 10,654,837 - Wan , et al.
2020-05-19
Sulphamoylpyrrolamide Derivatives And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20200039931 - VANDYCK; Koen ;   et al.
2020-02-06
Sulphamoylaryl Derivatives And Use Thereof As Medicaments For The Treatment Of Liver Fibrosis
App 20190345145 - WAN; Zhao-Kui ;   et al.
2019-11-14
Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
Grant 10,457,638 - Vandyck , et al. Oc
2019-10-29
Glyoxamide substituted pyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
Grant 10,450,270 - VanDyck , et al. Oc
2019-10-22
Capsid Assembly Modulator Dosing Regimen
App 20190282542 - VANDYCK; Koen ;   et al.
2019-09-19
N-phenyl-carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
Grant 10,398,677 - Vandyck , et al. Sep
2019-09-03
Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
Grant 10,377,709 - Vandyck , et al. A
2019-08-13
Sulfamoyl-arylamides And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20190077749 - VANDYCK; Koen ;   et al.
2019-03-14
Carboxamide Derivatives And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20190002406 - VANDYCK; Koen ;   et al.
2019-01-03
Sulphamoylthiophenamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
Grant 10,160,743 - Vandyck , et al. Dec
2018-12-25
Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B
Grant 10,125,094 - Vandyck , et al. November 13, 2
2018-11-13
Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
Grant 10,071,961 - Vandyck , et al. September 11, 2
2018-09-11
N-phenyl-carboxamide Derivatives And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20180153857 - VANDYCK; Koen ;   et al.
2018-06-07
Sulphamoylpyrrolamide Derivatives And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20180141905 - VANDYCK; Koen ;   et al.
2018-05-24
Sulfamoyl-arylamides And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20180127361 - VANDYCK; Koen ;   et al.
2018-05-10
Carboxamide Derivatives And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20180065929 - VANDYCK; Koen ;   et al.
2018-03-08
N-phenyl-carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
Grant 9,895,349 - Vandyck , et al. February 20, 2
2018-02-20
Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
Grant 9,884,818 - Vandyck , et al. February 6, 2
2018-02-06
Carboxamide Derivatives And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20170158634 - VANDYCK; Koen ;   et al.
2017-06-08
Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
Grant 9,567,299 - Vandyck , et al. February 14, 2
2017-02-14
Cyclized Sulfamoylarylamide Derivatives And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20170002025 - VENDEVILLE; Sandrine Marie Helene ;   et al.
2017-01-05
Sulphamoylpyrrolamide Derivatives And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20160347741 - VANDYCK; Koen ;   et al.
2016-12-01
Benzimidazole-imidazole Derivatives
App 20160340344 - Vandyck; Koen ;   et al.
2016-11-24
Carboxamide Derivatives And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20160264522 - VANDYCK; Koen ;   et al.
2016-09-15
Benzimidazole-imidazole derivatives
Grant 9,433,609 - Vandyck , et al. September 6, 2
2016-09-06
Benzimidazole-imidazole derivatives
Grant 9,427,428 - Vandyck , et al. August 30, 2
2016-08-30
Substituted quinazolinones as HCV inhibitors
Grant 9,382,261 - Vandyck , et al. July 5, 2
2016-07-05
Glyoxamide Substituted Pyrrolamide Derivatives And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20160176817 - VANDYCK; Koen ;   et al.
2016-06-23
Sulphamoylpyrrolamide Derivatives And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20160115125 - VANDYCK; Koen ;   et al.
2016-04-28
Sulphamoylthiophenamide Derivatives And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20160115149 - VANDYCK; Koen ;   et al.
2016-04-28
N-phenyl-carboxamide Derivatives And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20160051512 - Vandyck; Koen ;   et al.
2016-02-25
4,4-disubstituted-1,4-dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis B
Grant 9,233,933 - Vandyck , et al. January 12, 2
2016-01-12
Sulfamoyl-arylamides And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20160002155 - Vandyck; Koen ;   et al.
2016-01-07
Fused bicyclic sulfamoyl derivatives and the use thereof as medicaments for the treatment of hepatitis B
Grant 9,156,839 - Vandyck , et al. October 13, 2
2015-10-13
Sulfamoyl-arylamides And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20150274653 - Vandyck; Koen ;   et al.
2015-10-01
Sulfamoyl-arylamides And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20150266890 - Vandyck; Koen ;   et al.
2015-09-24
Hetero-bicyclic derivatives as HCV inhibitors
Grant 9,126,986 - Vandyck , et al. September 8, 2
2015-09-08
Fused Bicyclic Sulfamoyl Derivatives And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20150218159 - Vandyck; Koen ;   et al.
2015-08-06
Phenyl ethynyl derivatives as hepatitis C virus inhibitors
Grant 9,045,463 - McGowan , et al. June 2, 2
2015-06-02
Uracyl spirooxetane nucleoside phosphoramidates
Grant 9,012,428 - Jonckers , et al. April 21, 2
2015-04-21
Uracyl spirooxetane nucleoside phosphoramidates
Grant 9,006,209 - Jonckers , et al. April 14, 2
2015-04-14
Uracyl spirooxetane nucleosides
Grant 8,933,052 - Jonckers , et al. January 13, 2
2015-01-13
4,4-disubstituted-1,4-dihydropyrimidines And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20150005295 - Vandyck; Koen ;   et al.
2015-01-01
Quinazolinone Derivatives As Hcv Inhibitors
App 20140378485 - Vandyck; Koen ;   et al.
2014-12-25
Hetero-Bicyclic Derivatives As HCV Inhibitors
App 20140357626 - Vandyck; Koen ;   et al.
2014-12-04
Hetero-bicyclic derivatives as HCV inhibitors
Grant 8,815,849 - Vandyck , et al. August 26, 2
2014-08-26
Benzimidazole-imidazole derivatives
App 20140107172 - Vandyck; Koen ;   et al.
2014-04-17
Bis-benzimidazole derivatives as hepatitis C virus inhibitors
Grant 8,623,899 - McGowan , et al. January 7, 2
2014-01-07
Phosphoramidate derivatives of nucleosides
Grant 8,552,021 - Jonckers , et al. October 8, 2
2013-10-08
Uracyl Spirooxetane Nucleoside Phosphoramidates
App 20130244968 - Jonckers; Tim Hugo Maria ;   et al.
2013-09-19
Uracyl Spirooxetane Nucleoside Phosphoramidates
App 20130225520 - Jonckers; Tim Hugo Maria ;   et al.
2013-08-29
Uracyl Spirooxetane Nucleosides
App 20130217648 - Jonckers; Tim Hugo Maria ;   et al.
2013-08-22
Uracyl spirooxetane nucleosides
Grant 8,481,510 - Jonckers , et al. July 9, 2
2013-07-09
Hetero-Bicyclic Derivatives as HCV Inhibitors
App 20130123244 - Vandyck; Koen ;   et al.
2013-05-16
Cyclopropyl polymerase inhibitors
Grant 8,431,588 - Jonckers , et al. April 30, 2
2013-04-30
Uracyl cyclopropyl nucleotides
Grant 8,399,429 - Jonckers , et al. March 19, 2
2013-03-19
Phosphoramidate Derivatives of Nucleosides
App 20120225839 - Jonckers; Tim Hugo Maria ;   et al.
2012-09-06
Benzimidazole-imidazole Derivatives
App 20120219594 - Vandyck; Koen ;   et al.
2012-08-30
Bis-Benzimidazole Derivatives
App 20120172368 - Vandyck; Koen ;   et al.
2012-07-05
Bis-Benzimidazole Derivatives As Hepatitis C Virus Inhibitors
App 20120135953 - Mc Gowan; David ;   et al.
2012-05-31
Phenyl Ethynyl Derivatives As Hepatitis C Virus Inhibitors
App 20120136027 - Mc Gowan; David ;   et al.
2012-05-31
Cyclic Imidate Ligands
App 20120077989 - Noel; Timothy ;   et al.
2012-03-29
Uracyl Spirooxetane Nucleosides
App 20120065156 - Jonckers; Tim Hugo Maria ;   et al.
2012-03-15
Uracyl Cyclopropyl Nucleotides
App 20110230436 - Jonckers; Tim Hugo Maria ;   et al.
2011-09-22
Cyclopropyl Polymerase Inhibitors
App 20110092460 - Jonckers; Tim Hugo Maria ;   et al.
2011-04-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed